glp-1 naion GLP-1s are changing bodies… but what about the eyes? 👀 Here's what the current research shows: ▫ Rapid A1C reduction can trigger early worsening of DR (especially in moderate+ NPDR) ▫ More Zepbound And NAION: 1 Permanently

Coverage Carve-Outs: A growing number of employers cover GLP1s only for diabetes treatment, excluding weight-loss use entirely to limit financial exposure

It is suggested that Leu carriers with the Pro198Leu GPx1 allele had a 1.9-fold increased risk of non-ductal breast cancer and a 2.6-fold increased risk of developing grade 3 ductal tumors [92]

the ladder exists to spread that out

-Maintain a nutrient-dense diet to support healing, hormone balance, and energy

Similar content being viewed by others Subjects Main Dual agonism of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors (GLP-1R and GIPR, respectively), in the form of once-weekly injectable tirzepatide, is highly effective for treating people living with obesity and type 2 diabetes, resulting in greater weight loss than GLP-1R agonism alone 2